Disease: Plasminogen activitor inhibitor type 1 deficiency- congenital
- Development and application of global assays of hyper- and hypofibrinolysis
- Diagnosis of Immunoglobulin G4-related disease in a child with ligneous conjunctivitis: a novel mutation in plasminogen gene and plasminogen activator inhibitor-1 polymorphism
- Hypofibrinolysis in patients with hypercoagulability: the roles of urokinase and of plasminogen activator inhibitor
- Increased levels of hemostatic proteins are independent of inflammation in glycogen storage disease type Ia
- Inherited disorders of the fibrinolytic pathway
- Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease. a prospective study
- Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia
- Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis
- Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency